Global Scar treatment market size has been estimated at USD 19.2 billion in 2018 and is projected to reach USD 31.26 billion by 2023, at a CAGR of 10.24% during the forecast period from 2018 to 2023. Scar treatment is a procedure that is used to minimize the scars in a way that they look more consistent with the surrounding skin tone and texture. Scars are observable signs that persevere after a wound heals. They are inevitable results of wound or surgery, and their growth is unpredictable. Scars may be different in colour or texture from the surrounding healthy tissue, elevated or dipped, or particularly clear due to their size, shape, or location.
Increasing incidence of skin diseases and, subsequently, scars, will drive the global scar treatment market in the coming years. Additionally, technological advancements in scar treatment and growing appearance consciousness among consumers are also driving growth of the market. Side effects associated with scar treatment and high cost of treatment are restraining the market growth.
Scar Treatment Market outlook
The global scar treatment market is mainly segmented based on type of treatment into Topical treatment, Surface Treatment, Laser Treatment, Injectable Treatment and Invasive Surgical Treatment. Topical treatment is further segmented into creams, oils, gels and gel sheets. Surface treatment can be sub segmented into Dermabrasion, Chemical Peeling and Cryosurgery. Injectable treatment can be divided into tissue fillers and steroid injections. Based on scar type the market is bifurcated into Keloid and Hypertrophic Scars, Contracture Scars, Acne scars, Stretch scars and post-surgical scars. Basis on end users the market is segmented into hospitals, private clinics, pharmacies & drug stores and E-Commerce. Acne scars are the most common; their treatment involves antibiotic treatment or laser solutions.
Scar Treatment Market Geographical Analysis
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East and Africa. North America accounts for almost one-third of the market share and dominates the market. Latin America is expected to witness fastest growth with highest CAGR. Currently there is economic downturn in the European region but a healthy growth is expected in the forecast period.
Major players dominating the scar treatment market are Occulus Innovative Sciences Inc., Smith & Nephew PLC, Nutramarks Inc., Merz Inc., Enaltus LLC, CCA Industries Inc., Cynosure IncLumenis, Syneron Medical Ltd., Mölnlycke Health Care, Avita Medical Limited, Pacific World Corporation, Shanghai Fosun Pharmaceuticals Ltd. (AC. Alma Lasers), Valeant Pharmaceuticals International Inc., and Beijing Toplaser Technology Company Limited.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Treatment Type
5.1.1 Topical Treatment
5.1.1.1 Creams
5.1.1.2 Oils
5.1.1.3 Gels
5.1.1.4 Gel Sheets
5.1.2 Surface Treatment
5.1.2.1 Dermabrasion
5.1.2.2 Chemical Peeling
5.1.2.3 Cryosurgery
5.1.3 Laser Treatment
5.1.4 Injectable Treatment
5.1.4.1 Tissue Fillers
5.1.4.2 Steroid Injections
5.1.5 Invasive Surgical Treatment
5.2 By Scar Type
5.2.1 Keloid and Hypertrophic Scars
5.2.2 Contracture Scars
5.2.3 Acne Scars
5.2.4 Stretch Scars
5.2.5 Post-Surgical Scars
5.3 By End Users
5.3.1 Hospitals
5.3.2 Private Clinics
5.3.3 Pharmacies & Drug Stores
5.3.4 E-Commerce
6. Geographical Analysis
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.3.6 Australia
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Mexico
6.4.4 Argentina
6.4.5 Rest of Latin America
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Occulus Innovative Sciences Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Smith & Nephew PLC
8.3 Nutramarks Inc.
8.4 Merz Inc.
8.5 Enaltus LLC
8.6 CCA Industries Inc.
8.7 Cynosure IncLumenis
8.8 Syneron Medical Ltd.
8.9 Syneron Medical Ltd.
8.10 Avita Medical Limited
8.11 Pacific World Corporation
8.12 Shanghai Fosun Pharmaceuticals Ltd.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
